RxDoctor Payments DataLook up a doctor →

Sean McFadden, DO

Orthopaedic Surgery · Orlando, FLNPI 1538101522

Payments from drug & device makers

$4,086,385in general payments, 2019–2025

Across 281 payments — averaging $14,542 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$3M
  • Endo Pharmaceuticals Inc.$754K
  • Ipsen Innovation$193K
  • Pacira Therapeutics, Inc.$139K
  • Reel Surgical, Inc.$7K
  • Stryker$6K
  • plus $3K from 13 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,086,385 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$314,455
Medicare patients
596
Services billed
2,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →